BAXTER

Company Snapshot

Founded: 1931
Entity Type: Public
Employees: 37,500
Region: U.S.
Revenue: $11,244 Millions
Revenue Year: 2025
Segment: Medical Products and Therapies
Headquarter: Illinois, U.S.
Key Geographics: U.S., International
Corporate Address: One Baxter Parkway, Deerfield, Illinois, 60015 U.S. Tel.+1- 224-948-1812 www.baxter.com

Company Overview

Baxter is a global healthcare company that offers a range of essential healthcare products and services. It operates through four segments: medical products and therapies, healthcare systems and technologies, and pharmaceuticals.

Baxter offers cardiovascular products and technologies under its healthcare systems and technologies segment. The healthcare systems and technologies segment encompasses smart beds, patient monitoring and diagnostic systems, respiratory devices, and advanced surgical equipment, including surgical video and precision positioning technologies. The segment provides heart monitoring solutions to the global cardiovascular devices market.

It has manufacturing sites in 20 countries and serves over 100 markets. It has a strong presence in the U.S. and a significant presence in Europe, the Middle East, Africa, Asia-Pacific, Latin America, and Canada.

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

BAXTER In Reports

Cardiovascular Devices: Global Markets to 2030

BCC Research detailed report on cardiovascular devices market data using 2024 as the base year 2025 as the estimated year, and provides CAGR projections for the 2025–2030 forecast period.

Clinical Nutrition: Global Markets to 2031

Get insights into the clinical nutrition market, including enteral nutrition, parenteral nutrition, infant nutrition, regulatory trends and growth opportunities through 2030.

Chronic Kidney Disease: Global Markets and Technologies

BCC Research detailed report on chronic kidney disease market technologies, providing data from 2024, estimates for 2025, projections of compound annual growth rates through 2030.

Company's Business Segments

  • Medical Products and Therapies : Infusion Therapies and Technologies, Advanced Surgery
  • Healthcare Systems and Technologies : Care and Connectivity Solutions, Front Line Care
  • Pharmaceuticals : Injectables and Anesthesia, Drug Compounding
  • Other : Other sales primarily represent revenues earned by certain of our Manufacturing facilities from Contract manufacturing activities, Royalty income under a business development arrangement.

Applications/End User Industries

  • Hemodialysis
  • Peritoneal Dialysis
  • Intravenous (Iv) Administration
  • Infusion Pumps
  • Nutrition Products
  • Enteral Nutrition
  • Parenteral Nutrition Solutions
  • Surgical Products
  • Hemostats
  • Sealants
  • Surgical Instruments
  • Acute Therapies
  • Renal Replacement Therapy
  • Injectables
  • Wound Care
  • Rehabilitation
  • Surgical Specialties
  • Anesthesia
  • Cardiovascular Surgery
  • Dialysis Treatment
  • Dialysis Clinics
  • Renal Care Therapies
  • Long-Term Care Facilities
  • Home Healthcare Providers
  • Orthopedic Surgery
  • Neurosurgery
  • Cardiac Surgery
AI Sentiment